Astrocytes protect against copper-catalysed loss of extracellular glutathione

Neurochemical Research

Volumn 33, Issue 7, 2008, Pages 1410-1418

  Pope, Simon A S ^a,b   Milton, Rosemary ^a   Heales, Simon J R ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Astrocytes; Copper; Extracellular; Glutathione; Oxidative stress

Indexed keywords

ASCORBIC ACID; COPPER; GLUTATHIONE; PENTETIC ACID;

ANIMAL CELL; ARTICLE; ASTROCYTE; CONTROLLED STUDY; CULTURE MEDIUM; ELECTROCHEMISTRY; HUMAN; HUMAN CELL; NERVE CELL; NEUROPROTECTION; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT;

ANIMALS; ASCORBIC ACID; ASTROCYTES; ASTROCYTOMA; BRAIN NEOPLASMS; CATALYSIS; CELL LINE, TUMOR; CELLS, CULTURED; CHELATING AGENTS; COPPER; CULTURE MEDIA, CONDITIONED; EXTRACELLULAR SPACE; FLUORESCENT DYES; GLUTATHIONE; HUMANS; L-LACTATE DEHYDROGENASE; MALE; PENTETIC ACID; PHENANTHROLINES; RATS; RATS, WISTAR;

RATTUS;

EID: 44549085157     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-008-9602-3     Document Type: Article

References (51)

1. Winterbourn CC, Metodiewa D (1994) The reaction of superoxide with reduced glutathione. Arch Biochem Biophys 314:284-290
2. Sjoberg L, Eriksen TE, Revesz L (1982) The reaction of the hydroxyl radical with glutathione in neutral and alkaline aqueous solution. Radiat Res 89:255-263
3. Bains JS, Shaw CA (1997) Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death. Brain Res Rev 25:335-358
4. Sian J, Dexter DT, Lees AJ et al (1994) Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol 36:348-355
5. Sofic E, Lange KW, Jellinger K et al (1992) Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease. Neurosci Lett 142:128-130
6. Heales SJ, Davies SE, Bates TE et al (1995) Depletion of brain glutathione is accompanied by impaired mitochondrial function and decreased N-acetyl aspartate concentration. Neurochem Res 20:31-38
7. Jain A, Martensson J, Stole E et al (1991) Glutathione deficiency leads to mitochondrial damage in brain. Proc Natl Acad Sci USA 88:1913-1917
8. Bolanos JP, Heales SJ, Peuchen S et al (1996) Nitric oxide-mediated mitochondrial damage: a potential neuroprotective role for glutathione. Free Radic Biol Med 21:995-1001
9. Dringen R, Pfeiffer B, Hamprecht B (1999) Synthesis of the antioxidant glutathione in neurons: supply by astrocytes of CysGly as precursor for neuronal glutathione. J Neurosci 19:562-569
10. Gegg ME, Clark JB, Heales SJ (2005) Co-culture of neurones with glutathione deficient astrocytes leads to increased neuronal susceptibility to nitric oxide and increased glutamate-cysteine ligase activity. Brain Res 1036:1-6
11. Sagara JI, Miura K, Bannai S (1993) Maintenance of neuronal glutathione by glial cells. J Neurochem 61:1672-1676
12. Sagara J, Makino N, Bannai S (1996) Glutathione efflux from cultured astrocytes. J Neurochem 66:1876-1881
13. Hirrlinger J, Schulz JB, Dringen R (2002) Glutathione release from cultured brain cells: multidrug resistance protein 1 mediates the release of GSH from rat astroglial cells. J Neurosci Res 69:318-326
14. Stewart VC, Stone R, Gegg ME et al (2002) Preservation of extracellular glutathione by an astrocyte derived factor with properties comparable to extracellular superoxide dismutase. J Neurochem 83:984-991
15. Dringen R, Kranich O, Hamprecht B (1997) The gamma-glutamyl transpeptidase inhibitor acivicin preserves glutathione released by astroglial cells in culture. Neurochem Res 22:727-733
16. Dringen R, Gutterer JM, Gros C et al (2001) Aminopeptidase N mediates the utilization of the GSH precursor CysGly by cultured neurons. J Neurosci Res 66:1003-1008
17. Tate SS, Meister A (1974) Interaction of gamma-glutamyl transpeptidase with amino acids, dipeptides, and derivatives and analogs of glutathione. J Biol Chem 249:7593-7602
18. McIntyre TM, Curthoys NP (1979) Comparison of the hydrolytic and transfer activities of rat renal gamma-glutamyltranspeptidase. J Biol Chem 254:6499-6504
19. Evans PJ, Tredger JM, Dunne JB et al (1996) Catalytic metal ions and the loss of reduced glutathione from University of Wisconsin preservation solution. Transplantation 62:1046-1049
20. Hua LL, Halliwell B (2001) Oxidation and generation of hydrogen peroxide by thiol compounds in commonly used cell culture media. Biochem Biophys Res Commun 286:991-994
21. Kachur AV, Koch CJ, Biaglow JE (1998) Mechanism of copper-catalyzed oxidation of glutathione. Free Radic Res 28:259-269
22. Wang XF, Cynader MS (2001) Pyruvate released by astrocytes protects neurons from copper-catalyzed cysteine neurotoxicity. J Neurosci 21:3322-3331
23. Linder MC, Hazegh-Azam M (1996) Copper biochemistry and molecular biology. Am J Clin Nutr 63:797S-811S
24. Waggoner DJ, Bartnikas TB, Gitlin JD (1999) The role of copper in neurodegenerative disease. Neurobiol Dis 6:221-230
25. DiDonato M, Sarkar B (1997) Copper transport and its alterations in Menkes and Wilson diseases. Biochim Biophys Acta 1360:3-16
26. Nagasaka H, Inoue I, Inui A et al (2006) Relationship between oxidative stress and antioxidant systems in the liver of patients with Wilson disease: hepatic manifestation in Wilson disease as a consequence of augmented oxidative stress. Pediatr Res 60:472-477
27. Lafon-Cazal M, Adjali O, Galeotti N et al (2003) Proteomic analysis of astrocytic secretion in the mouse. Comparison with the cerebrospinal fluid proteome. J Biol Chem 278:24438-24448
28. Wolff SP, Dean RT (1987) Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes. Biochem J 245:243-250
29. White AR, Cappai R (2003) Neurotoxicity from glutathione depletion is dependent on extracellular trace copper. J Neurosci Res 71:889-897
30. Dringen R, Kussmaul L, Hamprecht B (1998) Detoxification of exogenous hydrogen peroxide and organic hydroperoxides by cultured astroglial cells assessed by microtiter plate assay. Brain Res Protoc 2:223-228
31. Riederer P, Sofic E, Rausch WD et al (1989) Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J Neurochem 52:515-520
32. Rapisarda VA, Volentini SI, Farias RN et al (2002) Quenching of bathocuproine disulfonate fluorescence by Cu(I) as a basis for copper quantification. Anal Biochem 307:105-109
33. Wee LM, Long LH, Whiteman M et al (2003) Factors affecting the ascorbate- and phenolic-dependent generation of hydrogen peroxide in Dulbecco's Modified Eagles Medium. Free Radic Res 37:1123-1130
34. Wilson JX, Peters CE, Sitar SM et al (2000) Glutamate stimulates ascorbate transport by astrocytes. Brain Res 858:61-66
35. Lonnrot K, Metsa-Ketela T, Molnar G et al (1996) The effect of ascorbate and ubiquinone supplementation on plasma and CSF total antioxidant capacity. Free Radic Biol Med 21:211-217
36. Dringen R, Hirrlinger J (2003) Glutathione pathways in the brain. Biol Chem 384:505-516
37. Kapaki E, Zournas C, Kanias G et al (1997) Essential trace element alterations in amyotrophic lateral sclerosis. J Neurol Sci 147:171-175
38. Jimenez-Jimenez FJ, Molina JA, Aguilar MV et al (1998) Cerebrospinal fluid levels of transition metals in patients with Parkinson's disease. J Neural Transm 105:497-505
39. Stuerenburg HJ (2000) CSF copper concentrations, blood-brain barrier function, and coeruloplasmin synthesis during the treatment of Wilson's disease. J Neural Transm 107:321-329
40. Gutteridge JM (1984) Copper-phenanthroline-induced site-specific oxygen-radical damage to DNA. Detection of loosely bound trace copper in biological fluids. Biochem J 218:983-985
41. Winyard PG, Pall H, Lunec J et al (1987) Non-caeruloplasmin-bound copper ('phenanthroline copper') is not detectable in fresh serum or synovial fluid from patients with rheumatoid arthritis. Biochem J 247:245-246
42. Gaeta A, Hider RC (2005) The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy. Br J Pharmacol 146:1041-1059
43. Pall HS, Williams AC, Blake DR et al (1987) Raised cerebrospinal-fluid copper concentration in Parkinson's disease. Lancet 2:238-241
44. Basun H, Forssell LG, Wetterberg L et al (1991) Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease. J Neural Transm Park Dis Dement Sect 3:231-258
45. Brown DR (2004) Role of the prion protein in copper turnover in astrocytes. Neurobiol Dis 15:534-543
46. Brown DR, Qin K, Herms JW et al (1997) The cellular prion protein binds copper in vivo. Nature 390:684-687
47. Brown DR, Kozlowski H (2004) Biological inorganic and bioinorganic chemistry of neurodegeneration based on prion and Alzheimer diseases. Dalton Trans 1907-1917
48. Borchardt T, Camakaris J, Cappai R et al (1999) Copper inhibits beta-amyloid production and stimulates the non-amyloidogenic pathway of amyloid-precursor-protein secretion. Biochem J 344(Pt 2):461-467
49. Terada K, Kawarada Y, Miura N et al (1995) Copper incorporation into ceruloplasmin in rat livers. Biochim Biophys Acta 1270:58-62
50. Bunton CA (1949) Oxidation of -diketones and -keto-acids by hydrogen peroxide. Nature 163:444
51. Flohe L, Budde H, Hofmann B (2003) Peroxiredoxins in antioxidant defense and redox regulation. Biofactors 19:3-10